[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US20030003166A1 - Immunity enhancing supplements for lung support - Google Patents

Immunity enhancing supplements for lung support Download PDF

Info

Publication number
US20030003166A1
US20030003166A1 US09/842,428 US84242801A US2003003166A1 US 20030003166 A1 US20030003166 A1 US 20030003166A1 US 84242801 A US84242801 A US 84242801A US 2003003166 A1 US2003003166 A1 US 2003003166A1
Authority
US
United States
Prior art keywords
composition
matter
vitamin
extract
root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/842,428
Inventor
Albert Fleischner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goen Group Inc
Original Assignee
Goen Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goen Group Inc filed Critical Goen Group Inc
Priority to US09/842,428 priority Critical patent/US20030003166A1/en
Assigned to GOEN GROUP, INC. reassignment GOEN GROUP, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FLEISCHNER, ALBERT M.
Priority to US10/191,272 priority patent/US6841176B2/en
Publication of US20030003166A1 publication Critical patent/US20030003166A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/90Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger

Definitions

  • This invention relates to the evolving science that several lung disorders are believed to be characterized by low glutathione levels. Glutathione is involved in numerous vital processes. Low glutathione levels have been implicated in inflammatory lung disorders and have been linked to abnormalities in the lung surfactant system and can cause abnormalities in the epithelial lining fluid. Reduced glutathione levels are a risk factor for chronic diseases 1 . Glutathione levels reduce naturally as we age; elderly people may then be at risk because of a decreased capacity to maintain many metabolic and detoxification reactions mediated by glutathione 2 . The key ingredient in this invention, N-Acetyl Cysteine, increases intercellular glutathione and has been shown to reduce the number of infectious bacteria in chronic bronchitis caused by smoking.
  • N-Acetyl Cysteine is a better source of glutathione than taking glutathione itself because less than half of supplemental glutathione gets out of the digestive system and into the body.
  • N-Acetyl Cysteine is a powerful antioxidant, antitoxin and immune support substance.
  • the invention discloses the formula sets that embody the invention of the supplement composition for increasing glutathione and antioxidant and antitoxin levels to achieve and maintain a healthy status.
  • antioxidants seem to help protect lung function and may help prevent asthma, emphysema and chronic bronchitis.
  • the difference between people with above-average levels of all the major antioxidants and those with below-average levels is about equivalent to the difference between the lung function of nonsmokers versus those who've smoked a pack a day for 10 years. 3
  • N-Acetyl Cysteine works to maintain glutathione and related antioxidant levels that normally decrease with stress, injury, exercise or age, while enhancing vitamin C's ability to support the immune system. This is particularly important since, as the body ages, the ability to digest and absorb protein is reduced over the years, resulting in shortages that lead to disease. Key groups that become oxidized are smokers, those deficient in antioxidants, those under stress and those who are aging. Oxidization makes us more susceptible to viral infection. Studies at the Louisville School of Medicine clearly show that glutathione possesses a unique ability to slow the aging process. 4
  • N-Acetyl Cysteine may reduce the elevated bacterial counts that are often seen in the lungs of smokers with chronic bronchitis.
  • N-Acetyl Cysteine may reduce the elevated bacterial counts that are often seen in the lungs of smokers with chronic bronchitis.
  • people with chronic bronchitis who took N-Acetyl Cysteine showed an improved ability to expectorate and a reduction in cough severity. 11 These benefits may result from N-Acetyl Cysteine's capacity to reduce the viscosity of sputum. 12
  • N-Acetyl Cysteine has been shown to provide protection against free radicals as well as against a variety of toxic hazards such as: acrolein (found in barbecue and cigarette smoke and auto exhaust), bromobenzene, paraquat (a toxic herbicide) and the side effects of cyclophosphamide and adrimycin (anti-cancer drugs). 13 Diseases in which free radicals play a role include cancer, AIDS, cirrhosis and many others. According to a study at Stanford University, patients given N-Acetyl Cysteine daily for six weeks were roughly twice as likely to survive for two years as the subject that did not take N-Acetyl Cysteine. 14
  • N-Acetyl Cysteine has been shown to have important chemopreventive properties and may provide protection against different mutagens and carcinogens in different stages of carcinogenesis. 15 A study at Harvard Medical School found that while glutathione aids in the protection of all cells and membranes, it is especially able to enhance immune system cells, protecting against damage from radiation and helping to reduce the side effects of chemotherapy, x-rays and alcohol.
  • N-Acetyl Cysteine has reached the Phase III trial stage in chemoprevention in Europe and has been used in clinical practice there for more than 30 years. In large groups of patients with chronic obstructive lung disease, N-Acetyl Cysteine has been a safe agent with minor effects even when prescribed for a prolonged period. 16
  • N-Acetyl Cysteine is an excellent mucolytic agent. It keeps the membranes of the respiratory system moist, thereby lessening the irritation of dry air, dust and pollutants. It also helps the immune system to do its job properly in the respiratory tract.
  • composition of each unit of the lung support supplement includes any combination of the specified range of the following ingredients: Vitamin A (as retinyl palmitate) 1,000 IU-10,000 IU Vitamin B 6 (as pyridoxine HCI) 1 mg-50 mg N-Acetyl-cysteine 25 mg-500 mg Deglychrrhizinated licorice root extract 25 mg-200 mg Matricaria chamomile (flowering tops) 10 mg-150 mg Slippery elm bark 10 mg-150 mg Sarsaparilla 25 mg-100 mg Astralagus root 10 mg-100 mg Gotu kola leaf extract (10% asiaticosides) 10 mg-50 mg Turmeric rhizome standardized extract 5 mg-20 mg (95% curcuminoids)
  • a representative formula for lung support supplement is as follows, one tablet contains: Vitamin A (as retinyl palmitate) 1,250 IU Vitamin B 6 (as pyridoxine HCI) 5 mg N-Acetyl-cysteine 250 mg Deglychrrhizinated licorice root extract 100 mg Matricaria chamomile (flowering tops) 75 mg Slippery elm bark 75 mg Sarsaparilla root 50 mg Astralagus root 25 mg Gotu kola leaf extract (10% asiaticosides) 225 mg Turmeric rhizome standardized extract 125 mg (95% curcuminoids)
  • Vitamin A maintains the cells that line the respiratory tract. It is vital for normal reproduction, growth and development. Vitamin A has also been shown to be crucial to the immune system, ultimately forming an important defense against diseases. It is an antioxidant that is necessary for new cell growth. Vitamin A deficiency has been associated with greater susceptibility to carcinogens and an increased risk of cancer. By strengthening the immune system, it increases resistance to infections, including colds, sore throats, flu, and bronchitis 18 .
  • Vitamin B6 acting as a coenzyme, aids in immune system function and in antibody production. It plays a role in cancer immunity and aids in the prevention of arteriosclerosis 19 .
  • N-Acetyl Cysteine is used for the reasons set forth above.
  • Deglycyrrhizinated licorice root soothes inflamed mucous membranes (demulcent effect) of the lungs and has expectorant properties 20 . It also has antiviral properties 21&22 .
  • Chamomile is used to soothe respiratory tract inflammation 23 . It has been suggested that there is a stimulation of local prostaglandin synthesis, thus strengthening the protective mucosal barrier against ulceration 24 .
  • the chief constituent of slippery elm bark is mucilage, which has demulcent, emollient and nutritive properties 25 .
  • Sarsaparilla was used as an expectorant and cough remedy as early as 1738 in Europe; it then gained favor in the colonies. While its mode of action is obscure, it may aid in the absorption of other ingredients 26 .
  • Sarsaparilla root protects against free radical harm from radiation exposure 27 .
  • Astragalus root acts as a tonic to protect the immune system 28 . It is traditionally considered to benefit the body's resistance, reduce swelling and regenerate tissue. Modem uses include support for those suffering from the common cold, immune-deficiency related problems (including AIDS, cancer and tumors) and influenza; it is known to strengthen the body's defenses and is effective for chronic lung weakness 29 .
  • Gotu kola leaf extract has been used to bring down a fever and to relieve colds and upper respiratory infections.
  • Gotu kola has anti-inflammatory, anticonvulsant, antidepressant and analgesic properties 30 . Extracts have been found to promote wound healing 31 . This herb aids in the elimination of excess fluids and shrinks tissues 32 .
  • Turmeric has anti-inflammatory and cytotoxic effects 33 .
  • Regular dietary intake of turmeric provides effective antimutagen action and may be useful in chemoprevention 34 .
  • In vitro and in vivo experiments have found that turmeric has antihepatotoxic and antibacterial effects 35 .
  • the protective, antioxidant effects of turmeric and curcumin were greater than those of vitamins E and A 36 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Supplement compositions designed to support healthy lung function and to help strengthen the immune system.

Description

    BACKGROUND
  • The prior art regarding this invention arises from distinct areas not heretofore combined to create new and useful formula sets or new and useful improvements thereof regarding Immunity Enhancing Supplements for Lung Support. [0001]
  • This invention relates to the evolving science that several lung disorders are believed to be characterized by low glutathione levels. Glutathione is involved in numerous vital processes. Low glutathione levels have been implicated in inflammatory lung disorders and have been linked to abnormalities in the lung surfactant system and can cause abnormalities in the epithelial lining fluid. Reduced glutathione levels are a risk factor for chronic diseases[0002] 1. Glutathione levels reduce naturally as we age; elderly people may then be at risk because of a decreased capacity to maintain many metabolic and detoxification reactions mediated by glutathione2. The key ingredient in this invention, N-Acetyl Cysteine, increases intercellular glutathione and has been shown to reduce the number of infectious bacteria in chronic bronchitis caused by smoking. N-Acetyl Cysteine is a better source of glutathione than taking glutathione itself because less than half of supplemental glutathione gets out of the digestive system and into the body. In addition, N-Acetyl Cysteine is a powerful antioxidant, antitoxin and immune support substance.
  • Albert M. Fleischner, Ph.D., has a doctorate in Pharmaceutical Chemistry from Rutgers University and has had over thirty years experience in the pharmaceutical industry with firms such as Schering-Plough Corporation, Roberts Pharmaceutical Corporation, Lehn & Fink Division of Sterling Drugs, Bradley Pharmaceutical Corporation, Amerchol Division of CPC and the Goen Group companies. He has a number of published papers and two previously granted patents and has several patents pending. [0003]
  • Not only do the lungs enable us to breathe, but in doing so they help the body eliminate waste gasses. When air is pulled in through the nose and mouth, it enters the trachea and moves down to the broncus, which divide into left and right bronchial tubes. These tubes carry air into the lungs where it is further divided into alveoli, little air sacs, which hold oxygen. As blood flows into the lungs through the capillaries, it brings with it carbon dioxide and other waste gasses. The carbon dioxide and waste gasses switch places with the oxygen as you breathe and the waste gasses are eliminated as you exhale. The oxygen is then distributed throughout the body. [0004]
  • SUMMARY
  • The invention discloses the formula sets that embody the invention of the supplement composition for increasing glutathione and antioxidant and antitoxin levels to achieve and maintain a healthy status. According to a Cornell University study, antioxidants seem to help protect lung function and may help prevent asthma, emphysema and chronic bronchitis. Specifically, in terms of lung function as measured by how much air the lungs could expel, the difference between people with above-average levels of all the major antioxidants and those with below-average levels is about equivalent to the difference between the lung function of nonsmokers versus those who've smoked a pack a day for 10 years.[0005] 3
  • N-Acetyl Cysteine works to maintain glutathione and related antioxidant levels that normally decrease with stress, injury, exercise or age, while enhancing vitamin C's ability to support the immune system. This is particularly important since, as the body ages, the ability to digest and absorb protein is reduced over the years, resulting in shortages that lead to disease. Key groups that become oxidized are smokers, those deficient in antioxidants, those under stress and those who are aging. Oxidization makes us more susceptible to viral infection. Studies at the Louisville School of Medicine clearly show that glutathione possesses a unique ability to slow the aging process.[0006] 4
  • Glutathione levels in the blood and tissues decrease with age[0007] 5; higher glutathione levels are related to higher levels of physical health.6 Exposure to glutathione can enhance our antioxidant defenses.7 In a double-blind study, individuals with chronic bronchitis showed a significant reduction in the number of exacerbations of their illness.8 Smokers have also benefited from taking N-Acetyl Cysteine9. In addition to helping break up mucus, N-Acetyl Cysteine may reduce the elevated bacterial counts that are often seen in the lungs of smokers with chronic bronchitis.10 In another study, people with chronic bronchitis who took N-Acetyl Cysteine showed an improved ability to expectorate and a reduction in cough severity.11 These benefits may result from N-Acetyl Cysteine's capacity to reduce the viscosity of sputum.12
  • N-Acetyl Cysteine has been shown to provide protection against free radicals as well as against a variety of toxic hazards such as: acrolein (found in barbecue and cigarette smoke and auto exhaust), bromobenzene, paraquat (a toxic herbicide) and the side effects of cyclophosphamide and adrimycin (anti-cancer drugs).[0008] 13 Diseases in which free radicals play a role include cancer, AIDS, cirrhosis and many others. According to a study at Stanford University, patients given N-Acetyl Cysteine daily for six weeks were roughly twice as likely to survive for two years as the subject that did not take N-Acetyl Cysteine.14
  • In reviewing approximately 200 published studies, there was overwhelming evidence that antioxidants are associated with reduced cancer incidence. Antioxidants neutralize free radicals, which are produced by normal metabolic activity. Without antioxidants, free radicals would damage cells and DNA and is a major factor in cancer and aging. Cigarette smoke contains oxidants as well as several precarcinogens. Metabolism of carcinogens and the steps of carcinogenesis are a balance between metabolic activation and detoxification, formation and scavenging of radicals and DNA damage and repair. This suggests that carcinogenic compounds can initiate tumor growth only when they saturate detoxification pathways. Glutathione plays a role in the detoxification of xenobiotics. N-Acetyl Cysteine has been shown to have important chemopreventive properties and may provide protection against different mutagens and carcinogens in different stages of carcinogenesis.[0009] 15 A study at Harvard Medical School found that while glutathione aids in the protection of all cells and membranes, it is especially able to enhance immune system cells, protecting against damage from radiation and helping to reduce the side effects of chemotherapy, x-rays and alcohol.
  • N-Acetyl Cysteine has reached the Phase III trial stage in chemoprevention in Europe and has been used in clinical practice there for more than 30 years. In large groups of patients with chronic obstructive lung disease, N-Acetyl Cysteine has been a safe agent with minor effects even when prescribed for a prolonged period.[0010] 16
  • N-Acetyl Cysteine is an excellent mucolytic agent. It keeps the membranes of the respiratory system moist, thereby lessening the irritation of dry air, dust and pollutants. It also helps the immune system to do its job properly in the respiratory tract. A study conducted by the Departments of Pulmonology and Surgery at Maastricht University and at the Asthma Centre Homerheide, both in The Netherlands, found that altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema.[0011] 17
  • Science already knows that N-Acetyl Cysteine has demonstrated in clinical studies that it can help protect, prevent and repair damaged cells and DNA. This invention takes that information and embodies it in a new and useful set of formulae, disclosed herein.[0012]
  • We now discuss in detail the most preferred version, variants or embodiments of the invention. First, a few words on terminology. The claim term “a” includes one and more than one. The claim term “label” is used as defined in the Federal Food Drug & Cosmetic Act and the regulations promulgated thereunder. We now turn to discussing in great detail the best (or “preferred”) versions (or “embodiments”) of the invention. [0013]
  • The composition of each unit of the lung support supplement includes any combination of the specified range of the following ingredients: [0014]
    Vitamin A (as retinyl palmitate)  1,000 IU-10,000 IU
    Vitamin B6 (as pyridoxine HCI)  1 mg-50 mg
    N-Acetyl-cysteine  25 mg-500 mg
    Deglychrrhizinated licorice root extract  25 mg-200 mg
    Matricaria chamomile (flowering tops)  10 mg-150 mg
    Slippery elm bark  10 mg-150 mg
    Sarsaparilla  25 mg-100 mg
    Astralagus root  10 mg-100 mg
    Gotu kola leaf extract (10% asiaticosides) 10 mg-50 mg
    Turmeric rhizome standardized extract  5 mg-20 mg
    (95% curcuminoids)
  • A representative formula for lung support supplement is as follows, one tablet contains: [0015]
    Vitamin A (as retinyl palmitate) 1,250 IU
    Vitamin B6 (as pyridoxine HCI) 5 mg
    N-Acetyl-cysteine 250 mg
    Deglychrrhizinated licorice root extract 100 mg
    Matricaria chamomile (flowering tops) 75 mg
    Slippery elm bark 75 mg
    Sarsaparilla root 50 mg
    Astralagus root 25 mg
    Gotu kola leaf extract (10% asiaticosides) 225 mg
    Turmeric rhizome standardized extract 125 mg
    (95% curcuminoids)
  • The scientific rationale for the formulation is as follows: [0016]
  • Vitamin A maintains the cells that line the respiratory tract. It is vital for normal reproduction, growth and development. Vitamin A has also been shown to be crucial to the immune system, ultimately forming an important defense against diseases. It is an antioxidant that is necessary for new cell growth. Vitamin A deficiency has been associated with greater susceptibility to carcinogens and an increased risk of cancer. By strengthening the immune system, it increases resistance to infections, including colds, sore throats, flu, and bronchitis[0017] 18.
  • Vitamin B6, acting as a coenzyme, aids in immune system function and in antibody production. It plays a role in cancer immunity and aids in the prevention of arteriosclerosis[0018] 19.
  • N-Acetyl Cysteine is used for the reasons set forth above. [0019]
  • Deglycyrrhizinated licorice root soothes inflamed mucous membranes (demulcent effect) of the lungs and has expectorant properties[0020] 20. It also has antiviral properties21&22.
  • Chamomile is used to soothe respiratory tract inflammation[0021] 23. It has been suggested that there is a stimulation of local prostaglandin synthesis, thus strengthening the protective mucosal barrier against ulceration24.
  • The chief constituent of slippery elm bark is mucilage, which has demulcent, emollient and nutritive properties[0022] 25.
  • Sarsaparilla was used as an expectorant and cough remedy as early as 1738 in Europe; it then gained favor in the colonies. While its mode of action is obscure, it may aid in the absorption of other ingredients[0023] 26. Sarsaparilla root protects against free radical harm from radiation exposure27 .
  • Astragalus root acts as a tonic to protect the immune system[0024] 28. It is traditionally considered to benefit the body's resistance, reduce swelling and regenerate tissue. Modem uses include support for those suffering from the common cold, immune-deficiency related problems (including AIDS, cancer and tumors) and influenza; it is known to strengthen the body's defenses and is effective for chronic lung weakness29.
  • Gotu kola leaf extract has been used to bring down a fever and to relieve colds and upper respiratory infections. Gotu kola has anti-inflammatory, anticonvulsant, antidepressant and analgesic properties[0025] 30. Extracts have been found to promote wound healing31. This herb aids in the elimination of excess fluids and shrinks tissues32.
  • Turmeric has anti-inflammatory and cytotoxic effects[0026] 33. Regular dietary intake of turmeric provides effective antimutagen action and may be useful in chemoprevention34. In vitro and in vivo experiments have found that turmeric has antihepatotoxic and antibacterial effects35. The protective, antioxidant effects of turmeric and curcumin were greater than those of vitamins E and A36.
  • Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The specific formulas are included as a preferred embodiment of the composition formula ranges, and not to further qualify the description. Claim references to specific components include the component itself, as well as concentrates, metabolites, constituents, extracts or combinations of said ingredients. [0027]

Claims (4)

I claim:
1. A composition of matter intended to support healthy lung function,
(a) said composition of matter containing (i) N-Acetyl Cysteine, and (ii) Vitamin A, and (iii) Vitamin B6 and (iv) deglycyrrhizinated licorice root extract, and (v) matricaria chamomile (flowering tops), and (vi) slippery elm bark, and (vii) sarsaparilla root, and (viii) astragalus root, and (ix) gotu kola leaf extract (10% asiaticosides), and (x) turmeric rhizome standardized extract (95% curcuminoids).
(b) said composition of matter intended for ingestion in pill, capsule, tablet or liquid form; and
(c) said composition of matter not represented for use as a conventional food or as the sole item of a meal or diet; and
(d) said composition of matter labeled as a supplement for use in or by humans.
2. A composition of matter intended to support healthy lung function.
3. (a) said combination of matter containing (i) N-Acetyl Cysteine and (ii) additional dietary substances which support the primary ingredient's activities.
(b) same
(c) same
4. The supplement of claim wherein said ingredients are present in any combination thereof in the following approximate amounts:
Vitamin A (as retinyl palmitate) 1,000 IU-10,000 IU Vitamin B6 (as pyridoxine HCI)  1 mg-50 mg N-Acetyl-cysteine  25 mg-500 mg Deglychrrhizinated licorice root extract  25 mg-200 mg Matricaria chamomile (flowering tops)  10 mg-150 mg Slippery elm bark  10 mg-150 mg Sarsaparilla  25 mg-100 mg Astralagus root  10 mg-100 mg Gotu kola leaf extract (10% asiaticosides) 10 mg-50 mg Turmeric rhizome standardized extract  5 mg-20 mg (95% curcuminoids)
US09/842,428 2001-04-27 2001-04-27 Immunity enhancing supplements for lung support Abandoned US20030003166A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/842,428 US20030003166A1 (en) 2001-04-27 2001-04-27 Immunity enhancing supplements for lung support
US10/191,272 US6841176B2 (en) 2001-04-27 2002-07-09 Immunity enhancing supplements for lung support

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/842,428 US20030003166A1 (en) 2001-04-27 2001-04-27 Immunity enhancing supplements for lung support

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/191,272 Continuation-In-Part US6841176B2 (en) 2001-04-27 2002-07-09 Immunity enhancing supplements for lung support
US10/191,272 Continuation US6841176B2 (en) 2001-04-27 2002-07-09 Immunity enhancing supplements for lung support

Publications (1)

Publication Number Publication Date
US20030003166A1 true US20030003166A1 (en) 2003-01-02

Family

ID=25287267

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/842,428 Abandoned US20030003166A1 (en) 2001-04-27 2001-04-27 Immunity enhancing supplements for lung support
US10/191,272 Expired - Fee Related US6841176B2 (en) 2001-04-27 2002-07-09 Immunity enhancing supplements for lung support

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/191,272 Expired - Fee Related US6841176B2 (en) 2001-04-27 2002-07-09 Immunity enhancing supplements for lung support

Country Status (1)

Country Link
US (2) US20030003166A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009125232A2 (en) * 2008-04-07 2009-10-15 Nino Kurdadze Herbal mix for treating upper respiratory diseases and pharmaceutical forms based thereon
ITRM20090109A1 (en) * 2009-03-11 2010-09-12 Phytoremedial S R L COMPOSITIONS FOR PREVENTION AND / OR TREATMENT OF DISORDERS ASSOCIATED WITH MENOPAUSE.
WO2012016706A1 (en) * 2010-08-05 2012-02-09 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences Ag Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one chamomilla plant for the treatment of cancer
ITMI20132169A1 (en) * 2013-12-20 2015-06-21 Thompson S R L COMPOSITION FOR THE PREVENTION AND TREATMENT OF COPD AND RELATED SYMPTOMS

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1740196B1 (en) * 2004-03-23 2015-08-26 Lifeline Nutraceuticals Corporation Compositions and method for alleviating inflammation and oxidative stress in a mammal
US9265808B2 (en) 2004-03-23 2016-02-23 Lifeline Nutraceuticals Corporation Compositions for alleviating inflammation and oxidative stress in a mammal
CN102657788B (en) * 2012-05-15 2014-02-05 广州粤丰动物保健有限公司 Traditional Chinese medical composition for prevention and control of avian influenza and preparation method thereof
CN103432436A (en) * 2013-08-04 2013-12-11 李秀萍 Preparation method of traditional Chinese medicine for treating delicacy-overeating acute bronchitis

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009125232A2 (en) * 2008-04-07 2009-10-15 Nino Kurdadze Herbal mix for treating upper respiratory diseases and pharmaceutical forms based thereon
WO2009125232A3 (en) * 2008-04-07 2009-12-23 Nino Kurdadze Herbal mix for treating upper respiratory diseases and pharmaceutical forms based thereon
ITRM20090109A1 (en) * 2009-03-11 2010-09-12 Phytoremedial S R L COMPOSITIONS FOR PREVENTION AND / OR TREATMENT OF DISORDERS ASSOCIATED WITH MENOPAUSE.
WO2012016706A1 (en) * 2010-08-05 2012-02-09 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences Ag Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one chamomilla plant for the treatment of cancer
EP2420228A1 (en) * 2010-08-05 2012-02-22 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences AG Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one chamomilla plant for the treatment of cancer
CN103037855A (en) * 2010-08-05 2013-04-10 植物制药科学公司良姜鸦片酊研究所 Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one chamomilla plant for the treatment of cancer
US10028989B2 (en) 2010-08-05 2018-07-24 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences Ag Composition comprising Retinol, a precursor or a reaction product of it and a plant extract from at least one Chamomilla plant for the treatment of cancer
US10369180B2 (en) 2010-08-05 2019-08-06 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences Ag Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one Chamomilla plant for the treatment of cancer
ITMI20132169A1 (en) * 2013-12-20 2015-06-21 Thompson S R L COMPOSITION FOR THE PREVENTION AND TREATMENT OF COPD AND RELATED SYMPTOMS
WO2015092763A1 (en) * 2013-12-20 2015-06-25 Thompson S.R.L. Nutritional composition for the prevention and treatment of copd and related symptoms

Also Published As

Publication number Publication date
US6841176B2 (en) 2005-01-11
US20030072823A1 (en) 2003-04-17

Similar Documents

Publication Publication Date Title
Joshi et al. Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers
EP1556021B1 (en) Pharmaceutical compositions comprising flavonoids and menthol
JP6966998B2 (en) Formulations for the treatment of oral, throat and airway disorders
AU2018349244B2 (en) N-acetylneuraminic acid compositions and methods of use
US8394423B2 (en) Compositions comprising apocynin, ginkgo and ginger and uses thereof
GB2368012A (en) Preparation for the relief of inflammatory disease
Chidinma et al. Therapeutic effects of garlic: A review
KR20160050108A (en) Compositions for Improving Oral Hygiene comprising extracts derived from natural materials and Uses Thereof
US20030003166A1 (en) Immunity enhancing supplements for lung support
Albrecht et al. A combination of Tropaeolum majus herb and Armoracia rusticana root for the treatment of acute bronchitis
WO2011098394A2 (en) Composition for the treatment and prevention of anxiety disorders and dyssomnia
Pradhan et al. A comprehensive review on phytochemistry, molecular pharmacology, clinical and translational outfit of Ocimum sanctum L.
US20080175925A1 (en) Method and composition for the treatment of herpes virus
US9028888B2 (en) Compositions and methods for treatment and management of pain
US8895075B2 (en) Herbomineral formulation for treating sickle cell disease
Devade et al. Ayurvedic Remedies of Covid-19
Dvivedi et al. Effect of curcumin on glucose absorption: an experimental study on albino rats
Shahriari et al. Effect of chamomile on chemotherapy-induced neutropenia: a pilot open-label controlled trial
Palaskar et al. Oral Health Challenges during Chronic Diseases: Prevention and Treatment Using Functional Foods and Nutraceuticals
Tharakan et al. Effect of AC II, a herbal formulation on radiation-induced immunosuppression in mice
Ahmed et al. EVALUATING CLINICAL EFFICACY OF TULSI AEROSOL IN THE MANAGEMENT OF UPPER RESPIRATORY TRACT INFECTION WSR TO PRATISHYAY-A PILOT STUDY
KR20230060553A (en) Phamaceutical composition consisting of medicinal herbs extracts for preventing and treating the respiratory disease causing particulate watter in the air
Audrey et al. Evaluation of the anti-inflammatory activity of a gel based on Afzelia africana (fabaceae) leaves
JP2023527409A (en) Compositions for the management of COVID-19 and related diseases
EP3150214A1 (en) Compositions containing extracts of curcuma spp and zingiber officinale which are useful to reduce peripheral inflammation and pain

Legal Events

Date Code Title Description
AS Assignment

Owner name: GOEN GROUP, INC., NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FLEISCHNER, ALBERT M.;REEL/FRAME:012800/0871

Effective date: 20020319

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION